Karen R Sherwood David D M Nicholl Franz Fenninger Vivian Wu Paaksum Wong Vince Benedicto Davide P Cina Meng Wang Taylor D Pobran Mari L De Marco Anna Citlali Márquez Agatha N Jassem Inna Sekirov Muhammad G Morshed Mohammad Bardi Mypinder Sekhon Paul Keown Matthew Kadatz James H Lan
10.3389/fimmu.2021.753558
Front Immunol
2021 Sep 22;12:753558.
covid-19 immune response immunosuppressants induction therapy transplant
CC BY
https://pubmed.ncbi.nlm.nih.gov/34630432/
Basiliximab / therapeutic use COVID-19 / immunology Glomerulonephritis, IGA / therapy Graft Rejection / immunology Immunosuppressive Agents / therapeutic use Kidney Transplantation SARS-CoV-2 / physiology
Basiliximab / therapeutic use COVID-19 / immunology Glomerulonephritis, IGA / therapy Graft Rejection / immunology Immunosuppressive Agents / therapeutic use Kidney Transplantation SARS-CoV-2 / physiology Case Reports Research Support, Non-U.S. Gov't Adult Humans Immune Tolerance Immunity Male Perioperative Period Transcriptome Immunosuppressive Agents Basiliximab
PMC8492986
34630432
Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report
2021